David Saxon, an analyst from Needham, reiterated the Buy rating on Irhythm Technologies. The associated price target was raised to $180.00.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
David Saxon has given his Buy rating due to a combination of factors that highlight Irhythm Technologies’ strong performance and promising outlook. The company exceeded revenue expectations in the second quarter of 2025, prompting management to increase their revenue guidance for the year. This positive momentum is largely attributed to the success of the Zio Monitor, with Zio AT achieving record results and emerging as a key growth driver.
Additionally, Irhythm Technologies is on track to become free cash flow positive by 2026, which is a significant milestone. The company’s growth drivers suggest potential for further upside, leading to an increased price target of $180, up from $151. These factors collectively support the Buy rating, reflecting confidence in the company’s future performance.
In another report released on July 16, Robert W. Baird also maintained a Buy rating on the stock with a $160.00 price target.
Based on the recent corporate insider activity of 51 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of IRTC in relation to earlier this year.